Immunotherapie and Immunology news
When it comes to modern medicine, advancements in cancer treatment and immune system rejuvenation are among the most exciting fields of study. One such breakthrough involves Cytokine-Induced Killer (CIK) cells. These specialized immune cells are showing promise in the fight against cancer and even offer potential for rejuvenating the immune system, helping our bodies combat […]
Read More »Hematopoietic stem cell transplantation (HSCT) is a medical procedure that involves the transplantation of stem cells that are capable of forming blood cells. This advanced treatment option is used to treat various blood-related diseases such as leukemia, lymphoma, and multiple myeloma. HSCT has been found to be highly effective in treating these diseases and has […]
Read More »Stem cell transplant is a medical procedure that involves the transfer of stem cells from one person to another. This treatment is designed to replace damaged or diseased cells with healthy cells, leading to a new and improved life for patients. Stem cell transplant is also known as bone marrow transplant, which is a type […]
Read More »Biomedical engineering researchers developed a new cell classifier tool that takes a higher-resolution look at the life cycle of neuroepithelial stem cells, which led to the discovery and exploration of a new resting phase called Neural G0. This knowledge could help scientists to better understand glioma brain tumors and develop new methods of treatment.
Read More »National Institutes of Health and other agencies are funding high-throughput genomics and transcriptomics (‘omics) experiments that deposit digital samples of data into the public domain at a rapidly increasing scale.1,2 The importance of these digital samples of data is further illustrated by the growing number of linked peer-reviewed publications that demonstrate its scientific value.3,4 Investigations of cancer […]
Read More »Deleting the TFG-β receptor in NK cells overcame immune suppression and enabled anti-tumor activity in preclinical models. Preclinical research from The University of Texas MD Anderson Cancer Center finds that although glioblastoma stem cells (GSCs) can be targeted by natural killer (NK) cells, they are able to evade immune attack by releasing the TFG-β signaling […]
Read More »